Shares in Sanofi have come under pressure as it reported the results of a trial of atopic dermatitis (AD) candidate amlitelimab that met all objectives – but seem to have disappointed investors. The ...
If you frequently experience facial redness, irritation and small bumps, you may be dealing with rosacea, a common skin condition that impacts more than 14 million people in the U.S. alone, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback